Cargando…
Can development of asthma and bronchial hyperreactivity be reduced by subcutaneous immunotherapy in adult patients with allergic rhinitis?
BACKGROUND/AIM: Allergic rhinitis can be associated with bronchial hyperreactivity (BHR) and create an increased risk for allergic asthma development. We aimed to investigate the effects of subcutaneous immunotherapy (SCIT) on BHR and asthma development in adult patients with allergic rhinitis. MATE...
Autores principales: | TEPETAM, Fatma Merve, ÖRÇEN, Cihan, ÖZŞEKER, Zeynep Ferhan, DUMAN, Dildar, SARAÇ, Sema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387867/ https://www.ncbi.nlm.nih.gov/pubmed/37476897 http://dx.doi.org/10.55730/1300-0144.5643 |
Ejemplares similares
-
Bronchial hyperreactivity and spirometric impairment in polysensitized patients with allergic rhinitis
por: Ciprandi, Giorgio, et al.
Publicado: (2004) -
The phenotypic heterogeneity of obese and nonobese patients with severe asthma and comparison of omalizumab–mepolizumab treatment efficiency in these patients
por: Özden, Şeyma, et al.
Publicado: (2023) -
Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD
por: Tepetam, Fatma Merve, et al.
Publicado: (2023) -
Nasal hyperreactivity and inflammation in allergic rhinitis
por: Garrelds, I. M., et al.
Publicado: (1996) -
Comparison of omalizumab and mepolizumab treatment efficacy in patients with atopic and eosinophilic “Overlap” severe asthma: Biological agent preference in atopic-eosinophilic severe asthma
por: Tepetam, Fatma Merve, et al.
Publicado: (2023)